Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 6:06 PM View:  | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Nov-24 | Option Exercise | 3,323 | $1.24 | $4,120.52 | 2% 146.2K to 149.53K | |
| 20-Nov-24 6:06 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Nov-24 | Planned Option Sale | 3,323 | $42.12 | $139,973.00 | (2%) 149.53K to 146.2K | |
| 20-Nov-24 6:10 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 18-Nov-24 | Planned Option Sale | 25,000 | $41.14 | $1,028,520.00 | (21%) 119.02K to 94.02K | |
| 20-Nov-24 6:10 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 18-Nov-24 | Option Exercise | 25,000 | $14.22 | $355,500.00 | 27% 94.02K to 119.02K | |
| 09-Oct-24 5:23 PM View: | Thompson Tamar Director | Avidity Biosciences, Inc. (RNA) | 07-Oct-24 | Option Sale | 30,000 | $44.98 | $1,349,260.00 | (100%) 30.0K to 0 | |
| 09-Oct-24 5:23 PM View: | Thompson Tamar Director | Avidity Biosciences, Inc. (RNA) | 07-Oct-24 | Option Exercise | 30,000 | $27.63 | $828,900.00 | 100% 0 to 30.0K | |
| 03-Oct-24 4:09 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 01-Oct-24 | Option Exercise | 62,500 | $26.75 | $1,671,880.00 | 73% 85.39K to 147.89K | |
| 03-Oct-24 4:09 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 01-Oct-24 | Planned Option Sale | 62,500 | $47.62 | $2,976,110.00 | (42%) 147.89K to 85.39K | |
| 23-Sep-24 9:03 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 23-Sep-24 | Sale (Planned) | 25,000 | $43.95 | $1,098,730.00 | (23%) 110.39K to 85.39K | |
| 23-Sep-24 9:01 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 23-Sep-24 | Sale (Planned) | 32,880 | $44.00 | $1,446,720.00 | (12%) 267.54K to 234.66K | |
| 23-Sep-24 9:06 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 23-Sep-24 | Sale (Planned) | 13,153 | $44.00 | $578,737.00 | (16%) 82.17K to 69.02K | |
| 23-Sep-24 8:59 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 23-Sep-24 | Sale (Planned) | 11,510 | $44.00 | $506,440.00 | (11%) 107.86K to 96.36K | |
| 20-Sep-24 5:19 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Planned Option Sale | 5,000 | $45.73 | $228,658.00 | (3%) 151.2K to 146.2K | |
| 23-Sep-24 9:01 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Grant | 125,000 | -- | -- | 73% 172.16K to 297.16K | |
| 23-Sep-24 8:59 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Grant | 50,000 | -- | -- | 70% 71.36K to 121.36K | |
| 20-Sep-24 5:19 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Option Exercise | 5,000 | $1.24 | $6,200.00 | 3% 146.2K to 151.2K | |
| 23-Sep-24 9:06 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Grant | 50,000 | -- | -- | 114% 44.02K to 94.02K | |
| 23-Sep-24 9:03 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 19-Sep-24 | Grant | 50,000 | -- | -- | 105% 47.72K to 97.72K | |
| 13-Sep-24 4:17 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 11-Sep-24 | Planned Option Sale | 25,000 | $40.40 | $1,010,040.00 | (30%) 82.17K to 57.17K | |
| 13-Sep-24 4:25 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 11-Sep-24 | Planned Option Sale | 96,500 | $40.40 | $3,898,540.00 | (56%) 172.26K to 75.77K | |
| 13-Sep-24 4:17 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 11-Sep-24 | Option Exercise | 25,000 | $14.22 | $355,500.00 | 44% 57.17K to 82.17K | |
| 13-Sep-24 4:25 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 11-Sep-24 | Option Exercise | 96,500 | $25.24 | $2,435,860.00 | 127% 75.77K to 172.26K | |
| 13-Sep-24 4:25 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 11-Sep-24 | Sale (Planned) | 14,894 | $40.40 | $601,708.00 | (20%) 75.77K to 60.87K | |
| 10-Sep-24 6:26 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 06-Sep-24 | Gift | 22,500 | -- | -- | 13% 168.7K to 191.2K | |
| 10-Sep-24 6:26 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 06-Sep-24 | Gift | 22,500 | -- | -- | (12%) 191.2K to 168.7K | |
| 21-Aug-24 4:30 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Aug-24 | Option Exercise | 5,000 | $1.24 | $6,200.00 | 3% 168.7K to 173.7K | |
| 21-Aug-24 4:30 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Aug-24 | Planned Option Sale | 5,000 | $45.19 | $225,946.00 | (3%) 173.7K to 168.7K | |
| 07-Aug-24 5:46 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 06-Aug-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 14% 205.04K to 233.04K | |
| 07-Aug-24 5:46 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 06-Aug-24 | Planned Option Sale | 28,000 | $43.35 | $1,213,820.00 | (12%) 233.04K to 205.04K | |
| 05-Aug-24 9:11 AM View: | Moriarty John B Chief Legal Officer | Avidity Biosciences, Inc. (RNA) | 01-Aug-24 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 23-Jul-24 4:22 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Jul-24 | Planned Option Sale | 5,000 | $45.01 | $225,069.00 | (3%) 173.7K to 168.7K | |
| 23-Jul-24 4:22 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 19-Jul-24 | Option Exercise | 5,000 | $1.24 | $6,200.00 | 3% 168.7K to 173.7K | |
| 11-Jul-24 4:07 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 09-Jul-24 | Option Exercise | 28,000 | $1.24 | $34,720.00 | 14% 205.04K to 233.04K | |
| 11-Jul-24 4:07 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 09-Jul-24 | Planned Option Sale | 28,000 | $39.93 | $1,118,080.00 | (12%) 233.04K to 205.04K | |
| 20-Jun-24 6:48 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 18-Jun-24 | Sale (Planned) | 11,228 | $39.13 | $439,345.00 | (16%) 69.09K to 57.87K | |
| 20-Jun-24 6:47 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 18-Jun-24 | Sale (Planned) | 32,074 | $39.13 | $1,255,040.00 | (18%) 174.62K to 142.54K | |
| 20-Jun-24 6:49 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 18-Jun-24 | Sale (Planned) | 9,864 | $39.13 | $385,972.00 | (23%) 42.03K to 32.17K | |
| 20-Jun-24 6:47 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 18-Jun-24 | Sale (Planned) | 10,106 | $39.13 | $395,445.00 | (17%) 60.87K to 50.77K | |
| 20-Jun-24 6:48 PM View: | MacLean Michael F Chief Financial Officer | Avidity Biosciences, Inc. (RNA) | 17-Jun-24 | Grant | 50,000 | -- | -- | 152% 32.87K to 82.86K | |
| 20-Jun-24 6:47 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 17-Jun-24 | Grant | 125,000 | -- | -- | 156% 80.04K to 205.04K | |
| 20-Jun-24 6:49 PM View: | McCarthy Teresa Chief Human Resources Officer | Avidity Biosciences, Inc. (RNA) | 17-Jun-24 | Grant | 50,000 | -- | -- | 697% 7.17K to 57.17K | |
| 20-Jun-24 6:47 PM View: | Flanagan W. Michael CSTO | Avidity Biosciences, Inc. (RNA) | 17-Jun-24 | Grant | 50,000 | -- | -- | 194% 25.77K to 75.77K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 14-Jun-24 | Option Exercise | 35,767 | $1.24 | $44,351.10 | 32% 112.12K to 147.88K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 14-Jun-24 | Planned Option Sale | 35,767 | $40.08 | $1,433,480.00 | (24%) 147.88K to 112.12K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 13-Jun-24 | Option Exercise | 164,233 | $1.24 | $203,649.00 | 146% 112.12K to 276.35K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 13-Jun-24 | Planned Option Sale | 164,233 | $40.08 | $6,581,800.00 | (59%) 276.35K to 112.12K | |
| 14-Jun-24 7:03 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 13-Jun-24 | Sale (Planned) | 60,000 | $40.08 | $2,404,780.00 | (26%) 228.7K to 168.7K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 12-Jun-24 | Option Exercise | 100,000 | $1.24 | $124,000.00 | 89% 112.12K to 212.12K | |
| 14-Jun-24 6:58 PM View: | Boyce Sarah President and CEO Director | Avidity Biosciences, Inc. (RNA) | 12-Jun-24 | Planned Option Sale | 100,000 | $35.73 | $3,573,020.00 | (47%) 212.12K to 112.12K | |
| 14-Jun-24 7:03 PM View: | Levin Arthur A Director | Avidity Biosciences, Inc. (RNA) | 12-Jun-24 | Private Sale (Planned) | 40,000 | $35.07 | $1,402,630.00 | (15%) 268.7K to 228.7K |
